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Boron Neutron Capture Therapy 
A. H. Soloway, W. Tjarks, B. A. Barnum, F. G. Rong, R. F. Barth, I. M. Codogni 
and J. G. Wilson, Chem. Rev. 1998, 98, 1515. 
Properties for BNCT agents 
Low toxicity 





R. F. Barth, J. A. Coderre, M. G. H. Vicente, T. E. Blue, Clin.Cancer Res., 2005, 
11, 3987  
Persistence inside target cells  
High boron introduction in tumor tissue:  
20 – 35 µg 10B /1 gr cancer cells 
Concentration ratio cancer tissue/healthy tissue : 3 – 5 / 1 
Concentration ratio cancer tissue/blood : 5 / 1 
Efficient body scanning  
MRI/BNCT dual agent: general structure 
BIOLOGICAL VECTOR CARBORANE MOLECULAR PROBE 
[Gd-DOTA]- Dicarba-closo-dodecaborane Lipoprotein 
Examples of MRI/BNCT agents  
MEA01 AT101 
AC01 
Org. Biomol. Chem., 2008, 6, 4460                 Chem. Eur. J., 2013, 19, 721 – 728                     
Org. Biomol. Chem., 2014, 12, 2457-2467  
 
New decaborane functionalization strategy: 
Hydroboration reaction  
Efficient strategy for lipophilic 
moiety introduction  on boron 
cage: 
Yield product: 55 – 92 % 
U. Kusari, P. J. Carrol, L. G. Sneddon; Inorg. Chem., 2008, 47, 9203-9215 
New dual agent synthesis: PB01 
Synthesis of C-(2-hydroxy)-ethyl-C’-H-6-(hexadecil)-o-carborane (3) 
a) 1-hexadecene (3.5 eq), bmimCl (0.3 eq), toluene, 125°C, yield 43%; b) 3-butyn-1-ol (4 eq), bmimCl (0.3 eq), 
toluene, 100°C, yield 40% 
  
 Structure 3 : Isomer 1a 
 Chemical shift for C-H 
    1H: 4.1 ppm  
  13C: 60.35 ppm 
Structure 3’ : Isomer 2 
Chemical shift for C-H 
  1H: 3.8 ppm 
13C: 61.47 ppm 
a Molecular structure defined by X-ray diffrattometric study 
Structure acquired by Dott.ssa Domenica Marabello  
 
  
New dual agent synthesis: PB01 
General procedure:  
Synthesis of C-[R3-DOTAMA-C6]-acetamide-C’-H-6-(hexadecil)-o-carborane (6)  
a) 1-hexadecene (3.5 eq), bmimCl (0.3 eq), toluene, 125°C, yield 43%; b) 3-butyn-1-ol (4 eq), bmimCl (0.3 eq),  
toluene, 100°C, yield 40%; c) CrO3 (4 eq), H2SO4 (3M), acetone, room temperature, yield 77%  
d) N-hydroxysuccinimide [NHS] (1.15 eq), dicyclohexilcarbodiimide [DCC] (1.2 eq), CH2Cl2, room temperature;  
e) R3-DOTAMA-C6 (0.95 eq), diisopropylethylamine [DIEA] (0.95 eq), CH2Cl2, room temperature, yield: 13 – 42% 
 
ter-Butyl  Benzyl 
Protecting groups 
New dual agent synthesis: PB01 
Synthesis of PB01: 
a) i   R = ter-(Butyl)  CF3COOH (2 ml), CH2Cl2, room temperature, yield: > 99% 
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Comparison PB01-AT101 
Synthetic steps required: 6  
Synthetic steps required: 14 














NMRD PROFILE  
Dott.ssa Simonetta Geninatti Crich 
Dott. Diego Alberti 
Conclusions 
Synthesis of MRI/BNCT dual agent based on hydroboration reaction: 
   efficient strategy for lipophilic moiety introduction on boron cage 
   reduction of synthetic steps required  
 
Experimental evidence for molecular structure of precursor (3):  
X-ray diffractometric study    
 
Preliminary relaxometric tests on PB01 interaction with LDLs show  
a Nuclear Magnetic Relaxation Dispersion (NMRP) profile superior in  
comparison with AT101  
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